Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial of Zingo in China

Trial Profile

A clinical trial of Zingo in China

Phase of Trial: Phase II

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Mar 2017 New trial record
    • 09 Mar 2017 According to a Lees Pharmaceutical Holdings media release, the China Food and Drug Administration (CFDA) has granted priority review for the clinical trial application for Zingo.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top